These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2742942)

  • 1. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in schizophrenic patients.
    Chang WH; Lin SK; Jann MW; Lam YW; Chen TY; Chen CT; Hu WH; Yeh EK
    Biol Psychiatry; 1989 Jul; 26(3):239-49. PubMed ID: 2742942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacodynamics and pharmacokinetics of haloperidol and reduced haloperidol in guinea pigs.
    Chang WH; Jaw SS; Wu HS; Tsay L; Yeh EK
    Psychopharmacology (Berl); 1988; 96(3):285-8. PubMed ID: 3146762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interconversions between haloperidol and reduced haloperidol in schizophrenic patients and guinea pigs: a steady-state study.
    Chang WH; Lin SK; Jann MW
    J Clin Psychopharmacol; 1991 Apr; 11(2):99-105. PubMed ID: 2056148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced haloperidol: a factor in determining the therapeutic benefit of haloperidol treatment?
    Chang WH
    Psychopharmacology (Berl); 1992; 106(3):289-96. PubMed ID: 1570373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of smoking, CYP2D6 genotype, and concomitant drug intake on the steady state plasma concentrations of haloperidol and reduced haloperidol in schizophrenic inpatients.
    Pan L; Vander Stichele R; Rosseel MT; Berlo JA; De Schepper N; Belpaire FM
    Ther Drug Monit; 1999 Oct; 21(5):489-97. PubMed ID: 10519444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent reduced haloperidol/haloperidol ratios in schizophrenic patients.
    Chang WH; Hwu HG; Lane HY; Lin SK; Chen TY; Chen H; Wei HL; Lin WL; Lin HN
    Psychiatry Res; 1991 Sep; 38(3):215-25. PubMed ID: 1754634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interconversion between haloperidol and reduced haloperidol in healthy volunteers.
    Chakraborty BS; Hubbard JW; Hawes EM; McKay G; Cooper JK; Gurnsey T; Korchinski ED; Midha KK
    Eur J Clin Pharmacol; 1989; 37(1):45-8. PubMed ID: 2591462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6.
    Young D; Midha KK; Fossler MJ; Hawes EM; Hubbard JW; McKay G; Korchinski ED
    Eur J Clin Pharmacol; 1993; 44(5):433-8. PubMed ID: 8359179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacoclinical correlations in schizophrenic patients treated with haloperidol decanoate: clinical evaluations, concentrations of plasma and red blood cell haloperidol and its reduced metabolite, and plasma homovanillic acid.
    Aymard N; Viala A; Stein I; Caroli F
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Nov; 19(7):1119-35. PubMed ID: 8787036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced haloperidol/haloperidol ratios in plasma: polymorphism in Japanese psychiatric patients.
    Someya T; Takahashi S; Shibasaki M; Inaba T; Cheung SW; Tang SW
    Psychiatry Res; 1990 Feb; 31(2):111-20. PubMed ID: 2326392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of cytochrome P450 2D6 genotypes on haloperidol metabolism: a preliminary study in a psychiatric population.
    Someya T; Suzuki Y; Shimoda K; Hirokane G; Morita S; Yokono A; Inoue Y; Takahashi S
    Psychiatry Clin Neurosci; 1999 Oct; 53(5):593-7. PubMed ID: 10595685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced haloperidol and haloperidol: effects on homovanillic acid in caudate and prefrontal cortex.
    Chang WH; Wu HS; Tseng YT
    Biol Psychiatry; 1987 Nov; 22(11):1369-74. PubMed ID: 3663789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CYP2D6 genotypes on the metabolism of haloperidol in a Japanese psychiatric population.
    Someya T; Shimoda K; Suzuki Y; Sato S; Kawashima Y; Hirokane G; Morita S; Yokono A; Takahashi S
    Neuropsychopharmacology; 2003 Aug; 28(8):1501-5. PubMed ID: 12784098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol metabolism in psychiatric patients: importance of glucuronidation and carbonyl reduction.
    Someya T; Shibasaki M; Noguchi T; Takahashi S; Inaba T
    J Clin Psychopharmacol; 1992 Jun; 12(3):169-74. PubMed ID: 1629382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma homovanillic acid levels and subtyping of schizophrenia.
    Chang WH; Chen TY; Lee CF; Hung JC; Hu WH; Yeh EK
    Psychiatry Res; 1988 Mar; 23(3):239-44. PubMed ID: 3387499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of plasma and red blood cells reduced haloperidol concentrations to haloperidol reductase activity assayed in red blood cells in psychiatric population.
    Shibasaki M; Someya T; Takahashi S
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Mar; 17(2):257-67. PubMed ID: 8430218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro study on the involvement of CYP1A2, CYP2D6 and CYP3A4 in the metabolism of haloperidol and reduced haloperidol.
    Pan L; Belpaire FM
    Eur J Clin Pharmacol; 1999 Oct; 55(8):599-604. PubMed ID: 10541779
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The plasma levels of haloperidol and reduced haloperidol in Japanese psychiatric patients].
    Someya T; Shibasaki M; Takahashi S
    Yakubutsu Seishin Kodo; 1989 Jun; 9(2):207-15. PubMed ID: 2816093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese.
    Chang WH; Jann MW; Hwu HG; Chen TY; Lin SK; Wang JM; Ereshefsky L; Saklad SR; Richards AL; Lam YW
    J Formos Med Assoc; 1991 Jun; 90(6):572-8. PubMed ID: 1681004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.